| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | VP Technical Operations
1 company
Lloyd MacKenzie last filed a Form 4 in August 2018, as Chief Operating Officer at NGNE. Lloyd MacKenzie's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Lloyd MacKenzie has 7 Form 4 filings on record from March 2015 to August 2018, all as Chief Operating Officer at Neurogene (NGNE), 2015–2018.
The 10 reported transactions were 5 option or other derivative awards, 3 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $689K.
The largest open-market sale was 35,887 shares of NGNE at an average $18.67 on August 12, 2015, about $670K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.